Why in the news?
In 2018, a team found through in vitro studies that when breast cancer cell lines were treated with progesterone, two genes — SGK1 and NDRG1 — were produced in excess amounts (overexpressed). They also found that the expression of a few microRNAs was reduced (down regulated) in response to the hormone treatment.
- Two particular microRNAs that were down regulated were found to also regulate the expression of the SGK1 gene.
- A recent study has found that treatment of breast cancer cells with progesterone results in a downregulation of a long noncoding linc RNA known as the Down Syndrome Cell Adhesion Molecule (DSCAMAS1).
- As with progesterone therapy, the researcher found that with silencing of DSCAM- AS1 expression, the ability of breast cancer cells to invade and migrate is slowed down.
- In breast cancer patients, the amount of DSCAMAS1 present is elevated. The team also found that DSCAMAS1 behaves like a sponge and depletes the availability of another non-coding microRNA called the miR130a.
- And the level of estrogen receptor in breast cancer cells is increased, which serves as an indicator to begin hormonal therapy. (Source: The Hindu)
What are MicroRNAs (miRNAs)?
- MicroRNAs (miRNAs) are small noncoding RNAs that function as major players of posttranscriptional gene regulation in diverse species.
- It is the name of a family of molecules that helps cells control the kinds and amounts of proteins they make. That is, cells use microRNA to help control gene expression. Gene expression refers to whether a particular gene is making too much, too little or the normal amount of its protein at a particular time.
- Molecules of microRNA are found in cells and in the bloodstream.
- Along with genes that encode the information for making proteins, cells have genes that encode the information for making microRNA.
- In cancer cells, microRNA genes can be damaged by mutations. A mutation in a microRNA gene can leave the cell without that particular microRNA or reduce it to a low level in the cell.
- Abnormally low levels of a microRNA can lead to overexpression of genes that that microRNA regulates, and that can lead to cancer development and progression.